# Nuclide record abx-advanced-biochemical-compounds (company). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/companies/abx-advanced-biochemical-compounds/>
  a schema:Organization ;
  nuclide:kind "company" ;
  schema:identifier "abx-advanced-biochemical-compounds" ;
  schema:name "ABX advanced biochemical compounds"@en ;
  schema:alternateName "ABX advanced biochemical compounds GmbH"@en, "ABX GmbH"@en, "ABX"@en ;
  schema:description "ABX is a German maker of the precursors and kits behind PET imaging tracers, including PSMA agents for prostate cancer, and sponsors the trials that register them."@en ;
  schema:url <https://nuclide.cc/companies/abx-advanced-biochemical-compounds/>, <https://www.abx.de> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.abx.de>, <https://clinicaltrials.gov/search?lead=ABX%20advanced%20biochemical%20compounds> ;
  nuclide:tag "ctgov-sponsor" ;
  schema:addressCountry "DE" ;
  nuclide:indications <https://nuclide.cc/indications/prostate/> ;
  nuclide:technologies <https://nuclide.cc/technologies/psma-pet/> ;
  nuclide:drugs <https://nuclide.cc/drugs/psma-1007-f18/> .
